Summary
Operations research (OR) provides an excellent set of tools for decision makers who regulate the use of new treatments or medications. The decision about whether to use a new treatment must typically be made well before long-term trials or database studies can be conducted. However, large amounts of information about new treatments are available from the clinical trials required for drug registration. OR models can synthesize this information and use it to predict expected costs and benefits of long-term treatment use within a given population. Such analysis provides valuable additional information for the decision maker when a novel treatment is initially being considered. These analyses are like duct tape for the decision maker: they are designed to make use of the best currently available information to help current decisions, thereby bridging the gap until better information becomes available.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
World Health Organization (1999). 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Journal of Hypertension, 17, 151–83.
Hoerger, T.J., M.V. Bala, J.L. Eggleston, D.E. Hilleman, J.M. Neutel, and P.A. Tomondy (1998). A comparative costeffectiveness study of three drugs for the treatment of mild-to-moderate hypertension. Pharmacy and Therapeutics, 23, 245–67.
Richter, A., C. Ostrowski, M.P. Dombeck, K. Gondek, and J.L. Hutchinson (2001). Delphi panel on current hypertension treatment patterns. Clinical Therapeutics, 23, 160–7.
Richter, A., K. Gondek, C. Ostrowski, M.P. Dombeck, and S. Lamb (2001). Mild-to-moderate uncomplicated hypertension, further analysis of a cost-effectiveness study of five drugs. Managed Care Interface, 14, 61–69.
Penna, P., E. Cox, T. Joseph, L. Lehman, T. Morrow, A. Richter, J. Sowers, and D. Tepper (2000). Roundtable Discussion, Part I-Epidemiologic, demographic, and treatment challenges in hypertension. Managed Care Interface, Supplement C, 10–16.
Penna, P., E. Cox, T. Joseph, L. Lehman, T. Morrow, A. Richter, J. Sowers, and D. Tepper (2000). Roundtable Discussion, Part II-Development of a Pharmacoeconomic Model in Hypertension. Managed Care Interface, Supplement C, 17–23.
Penna, P., E. Cox, T. Joseph, L. Lehman, T. Morrow, A. Richter, J. Sowers, and D. Tepper (2000). Roundtable Discussion, Part III-Hypertension Management in Health Plans. Managed Care Interface, Supplement C, 24–31.
U.S. Department of Health and Human Services (2002). Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, http://www.hivatis.org/guidelines/adult/May23_02/AAMay23.pdf, Accessed February 4, 2002.
Vandamme, A.M., F. Houyez, D. Banhegyi, B. Clotet, G. De Schrijver, K.A. De Smet, W.W. Hall, R. Harrigan, N. Hellmann, K. Hertogs, C. Holtzer, B. Larder, D. Pillay, E. Race, J.C. Schmit, R. Schuurman, E. Schulse, A. Sonnerborg, and V. Miller (2001). Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up. Antiviral Therapy, 6, 21–39.
Yeni, P.G., S.M. Hammer, C.C. Carpenter, D.A. Cooper, M.A. Fischl, J.M. Gatell, B.G. Gazzard, M.S. Hirsch, D.M. Jacobsen, D.A. Katzenstein, J.S. Montaner, D.D. Richman, M.S. Saag, M. Schechter, R.T. Schooley, M.A. Thompson, S. Vella, and P.A. Volberding (2002). Antiretroviral treatment for adult HIV infection in 2002, updated recommendations of the International AIDS Society-USA Panel. Journal of the American Medical Association, 288, 222–35.
Mellors, J.W., A. Munoz, J.V. Giorgi, J.B. Margolick, C.J. Tassoni, P. Gupta, L.A. Kingsley, J.A. Todd, A.J. Saah, R. Detels, J.P. Phair, and C.R. Rinaldo (1997). Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of Internal Medicine, 126, 946–954.
American College of Surgeons (2003). Journal of the American College of Surgeons. http://www.facs.org, Accessed May 2003.
American Cancer Society (2003). http://www.cancer.org, Accessed May 2003.
National Comprehensive Cancer Network (2003). Clinical Practice Guidelines, http://www.nccn.org, Accessed May 2003.
National Cancer Institute (2003). Cancer Treatment PDQ® (Physician Data Query),-Health Professionals, http://www.nci.nih.gov/cancerinfo/pdq, Accessed May 2003.
DeVita, V.T., S. Hellman, and S.A. Rosenberg (2001). Cancer, Principles and Practice of Oncology. 6th Edition. Lippincott Williams and Wilkins, Philadelphia, PA.
Tengs T.O. and A. Wallace (2000). One thousand health-related quality-of-life estimates. Medical Care, 38, 583–637.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Richter, A. (2005). Duct Tape for Decision Makers: The Use of or Models in Pharmacoeconomics. In: Brandeau, M.L., Sainfort, F., Pierskalla, W.P. (eds) Operations Research and Health Care. International Series in Operations Research & Management Science, vol 70. Springer, Boston, MA. https://doi.org/10.1007/1-4020-8066-2_11
Download citation
DOI: https://doi.org/10.1007/1-4020-8066-2_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7629-9
Online ISBN: 978-1-4020-8066-1
eBook Packages: Springer Book Archive